The story of Viagra, and its parent company copyright, presents a challenging case study for investors. Originally a blockbuster drug, generating billions in revenue , its intellectual property lapse created a deluge of generic competition , significantly diminishing its market share . While some firms may attempt to capitalize on male sexual dysfu